|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | (2006.01) |
| C07K 16/40 | (2013.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3536712 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19162319.8 |
| Date of filing the European patent application | 2012-09-12 | |
| (97) | Date of publication of the European application | 2019-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161535392 P | 2011-09-16 | US | |
| 201161559162 P | 2011-11-14 | US | |
| 201261641321 P | 2012-05-02 | US |
| (72) |
SWERGOLD,, Gary , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6706,
US
|
| (54) | METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |
| METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |